A Biomarker for Who Exposure Will Actually Work On
- In male and female rats made alcohol-dependent through chronic intermittent ethanol vapor (or non-dependent controls), reactivity to a CO2 challenge was tested as a predictor of alcohol-seeking after either standard extinction or retrieval-extinction (a reactivation-based variant of cue exposure).
- CO2 reactivity differentially predicted long-term memory test outcomes depending on which of the two procedures the animal received.
- CO2-induced orexin/c-Fos colocalization, a separate physiological marker, did not track with CO2 reactivity or with long-term outcomes.
- The authors propose CO2 reactivity as a screening measure to identify which individuals are better candidates for standard cue exposure therapy versus a retrieval-extinction-based approach.
Cue exposure therapy (CET) is effective for some people with alcohol use disorder and not for others, and clinicians have no principled way to tell in advance which group a given client falls into. This paper, from the lab that first described the retrieval-extinction procedure in humans, proposes a candidate answer from the physiological side rather than another new protocol.
The Question Behind the Data
CET works by extinguishing the learned link between alcohol cues and craving, but relapse after CET is common enough that researchers have spent two decades looking for a variant that lasts. Retrieval-extinction, which briefly reactivates the memory before extinction training, is one such variant. Instead of testing whether retrieval-extinction beats standard extinction outright, this study asked a different question: does a physiological trait measured beforehand predict who benefits from which procedure.
What Reactivity Predicted, and What It Did Not
CO2 reactivity, an established index of anxiety-like physiological responding, tracked differently with later alcohol-seeking depending on whether the animal underwent extinction or retrieval-extinction, in both dependent and non-dependent groups. A second candidate marker, the overlap between CO2-induced activity and orexin neurons, showed no such relationship, which narrows the mechanistic story rather than widening it.
COreactivity could be used as a screening tool to determine whether an individual may be a good candidate for CET or a retrieval-extinction-based approach.
The evidence is from rats, not from patients in treatment for alcohol use disorder, and no version of a CO2-reactivity test has been validated in a clinical population; it answers a mechanistic question, not a bedside one.